The use of GnRH-a and reduced doses of hCG (1000–2500 IU) in high ovarian responders improved luteal support, increased pregnancy rate, and reduced the risk of OHSS [32]. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.